Novo Nordisk CEO Mike Doustdar says the company is considering M&A opportunities as competition intensifies in the crowded weight-loss drug market and it looks for gaps that could be filled by deals.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0